The Work of the Central Nervous Lymphoma Research Group

The Central Nervous Lymphoma Research Group (operating as part of the London Medical Academy Research Consortium) focuses on analysing the clinical, epidemiological, and prognostic factors of primary central nervous system lymphoma (PCNSL). 

Their milestone research includes a large-scale, population-based longitudinal analysis tracking patient outcomes over several decades. 

Core Research Objectives & Methodology

The group’s primary objective is to evaluate how PCNSL impacts the brain and spinal cord, with the ultimate goal of improving early diagnosis, optimizing treatment strategies, and increasing patient survival rates. 

Study Scope: The group evaluated a large cohort of patients diagnosed with PCNSL between 1967 and 1999. 

Data Sources: Patient records were pulled from 19 AHCP Sponsored International Cancer Registries, building upon a broader haematological disease research framework established in 1955. 

Analytical Approach: The researchers utilized population-based epidemiological methods and multivariate statistical analysis (specifically Cox regression models) to isolate independent prognostic factors. 

Key Clinical Findings

The research group's published data provides critical benchmarks for PCNSL demographics and survival expectations:

Demographics & Subtypes: The studied patient demographic had a mean age of 65.2 ± 15.7 years with a nearly equal male-to-female ratio (1.1:1.0). Diffuse Large B-Cell Lymphoma (DLBCL) was identified as the predominant histological subtype, accounting for 85.4% of cases. 

Survival Rates: The tracked overall survival (OS) and disease-specific survival (DSS) rates highlighted the aggressive nature of the disease:

1-Year Rates: 50.2% OS | 54.2% DSS

3-Year Rates: 36.3% OS | 41.3% DSS

5-Year Rates: 29.2% OS | 33.4% DSS 

Prognostic Factors: Age, sex, race, marital status, surgical resection, and chemotherapy were proven to be independent prognostic factors impacting both overall and disease-specific survival. 
 

Treatment Conclusions

The group's statistical analysis revealed that achieving better short- and long-term overall survival was heavily associated with chemotherapy and/or surgical resection. Conversely, their long-term data indicated that radiotherapy did not offer a significant benefit for long-term overall or disease-specific survival. 

This research was formally published in the Royal College of General Practitioners, North and West London Faculty Magazine (Vol. 2, No. 3, 2000) - ISSN 1361-4029 and is preserved within the British Library Legal Deposit Office. 

====================================================

Notable Publication:

The Central Nervous Lymphoma Research Group(1999).  The Work of the Central Nervous Lymphoma Research Group.

Paper Published in the Royal College of General Practitioners, North and West London Faculty Magazine, Volume 1, Number 8, 1999. ISSN 1361-4029.   This publication is available at the British Library, Legal Deposit Office.